Cholangiocarcinoma: Bridging the Gap Between the Clinic and the Laboratory

This presentation on cholangiocarcinoma covers epidemiology, including anatomical classification and risk factors; clinical management, including staging, treatment, and precision medicine; molecular pathogenesis, including the genomic landscape and the role of the demoplastic stroma. It also covers lab-to-clinic activities related to experimental disease models and identification of novel potential targets.

Chapters (Click to go to chapter start)

Anatomical classification
FGFR2 rearrangements and inhibitors
IDH1 and IDH2 mutations
Genetic landscape
Next-generation sequencing
Signaling pathways
Desmoplastic stroma
Projects in the lab



August 3, 2021

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

Daniela Sia, PhD

Daniela Sia, PhD

Assistant Professor of Medicine
Liver Diseases, Liver Cancer Program
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai

View full profile